Citation tools
"Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737–Mediated Cell Death in Malignant Human Glioma Cell Lines." Journal of Pharmacology and Experimental Therapeutics
356.2
(2016):
354-365.
Web. 24 April. 2024.